Cryosurgical ablation therapy for prostate cancer

Area of Science:

• Oncology
• Urology

Background:

• Prostate adenocarcinoma is the most common cancer in men and a leading cause of cancer-related death in American men.
• Established therapies for prostate cancer exist, but there is a need for effective minimally invasive treatment options.

Purpose of the Study:

• To evaluate the effectiveness and safety of cryotherapy for clinically localized prostate cancer.
• To assess the outcomes of cryotherapy in patients who have previously failed other treatments like radiation therapy.

Main Methods:

• Cryotherapy procedures for prostate cancer have been performed since 1993.
• A total of 643 cryosurgical procedures were analyzed, including patients with prior treatment failures.
• Recently developed targeted cryotherapy techniques using 6-8 probes were investigated.

Main Results:

• Cryotherapy has demonstrated effectiveness in selective patients with clinically localized prostate cancer.
• Targeted cryotherapy techniques show promising initial results.
• Complication rates for cryotherapy compare favorably to established prostate cancer therapies.

Conclusions:

• Cryotherapy is a minimally invasive procedure with high patient acceptance for prostate cancer treatment.
• It offers a viable option for patients who failed previous treatments.
• Cryotherapy is operator-dependent, requires a learning curve, and involves evolving technology.